Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026?
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and stronger recent gains.
Overview
Investors choosing between iShares Global Healthcare ETF (NYSEMKT:IXJ) and Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) may weigh broad global diversification and higher dividend yields against lower costs and specialized high-growth potential.
Both ETFs target the healthcare sector, but their geographic and industry scopes differ significantly. While one provides broad global exposure to medical giants, the other offers a focused play on the biotechnology and pharmaceutical innovation occurring on the Nasdaq. This analysis compares their costs, risk profiles, and recent performance.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield as of the close of trading on July 20.
Source
Originally published at www.fool.com.